Literature DB >> 21865402

Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease.

Michael Schumann1, Dorothee Günzel, Nataly Buergel, Jan F Richter, Hanno Troeger, Claudia May, Anja Fromm, Detlef Sorgenfrei, Severin Daum, Christian Bojarski, Martine Heyman, Martin Zeitz, Michael Fromm, Joerg-Dieter Schulzke.   

Abstract

BACKGROUND: Epithelial barrier defects are well known in coeliac disease, but the mechanisms are only poorly defined. It is unclear, whether barrier disturbance reflects upregulated epithelial transcytosis or paracellular leakage.
OBJECTIVE: To characterise the molecular structure and function of the epithelial tight junction (TJ) and mechanisms of its dysregulation.
METHODS: Molecular analysis of proteins involved in TJ assembly and their regulation was performed by western blotting and confocal microscopy correlated to electrophysiology.
RESULTS: A complex alteration of the composition of epithelial TJ proteins (with more pore-forming claudins like claudin-2 and a reduction in tightening claudins like claudin-3, -5 and -7) was found for protein expression and subcellular localisation, responsible for an increase in paracellular biotin-NHS uptake. In contrast, epithelial apoptosis was only moderately elevated (accounting for a minor portion of barrier defects) and epithelial gross lesions--for example, at cell extrusion zones, were absent. This TJ alteration was linked to an altered localisation/expression of proteins regulating TJ assembly, the polarity complex protein Par-3 and the serine-/threonine phosphatase PP-1.
CONCLUSIONS: Changes in cell polarity proteins Par-3 and PP-1 are associated with altered expression and assembly of TJ proteins claudin-2, -3, -5 and -7 and ZO-1, causing paracellular leakage in active coeliac disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865402     DOI: 10.1136/gutjnl-2011-300123

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

Review 1.  Zonulin, regulation of tight junctions, and autoimmune diseases.

Authors:  Alessio Fasano
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

2.  Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.

Authors:  J Luettig; R Rosenthal; C Barmeyer; J D Schulzke
Journal:  Tissue Barriers       Date:  2015-04-03

3.  PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Authors:  Ester Bonastre; Sara Verdura; Ilse Zondervan; Federica Facchinetti; Sylvie Lantuejoul; Maria Dolores Chiara; Juan Pablo Rodrigo; Julian Carretero; Enric Condom; Agustin Vidal; David Sidransky; Alberto Villanueva; Luca Roz; Elisabeth Brambilla; Suvi Savola; Montse Sanchez-Cespedes
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

Review 4.  The mucosal barrier at a glance.

Authors:  Marion M France; Jerrold R Turner
Journal:  J Cell Sci       Date:  2017-01-06       Impact factor: 5.285

Review 5.  The intestinal epithelial barrier: a therapeutic target?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

Review 6.  Bringing balance by force: live cell extrusion controls epithelial cell numbers.

Authors:  George T Eisenhoffer; Jody Rosenblatt
Journal:  Trends Cell Biol       Date:  2012-12-28       Impact factor: 20.808

Review 7.  Phosphatase regulation of intercellular junctions.

Authors:  Declan F McCole
Journal:  Tissue Barriers       Date:  2013-10-10

8.  Par-3 modulates intestinal epithelial barrier function through regulating intracellular trafficking of occludin and myosin light chain phosphorylation.

Authors:  Min Yu; Songwei Yang; Yuan Qiu; Guoqing Chen; Wensheng Wang; Chao Xu; Wenqiang Cai; Lihua Sun; Weidong Xiao; Hua Yang
Journal:  J Gastroenterol       Date:  2015-03-28       Impact factor: 7.527

Review 9.  Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics.

Authors:  Nina A Hering; Michael Fromm; Jörg-Dieter Schulzke
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

10.  Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells.

Authors:  Rita Rosenthal; Julia Luettig; Nina A Hering; Susanne M Krug; Uwe Albrecht; Michael Fromm; Jörg-Dieter Schulzke
Journal:  Int J Colorectal Dis       Date:  2016-12-15       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.